NeuroDerm
Clinical-stage pharmaceutical company that develops treatments for Central Nervous System (CNS) conditions
NeuroDerm has raised €12M across 1 funding round, most recently a Growth/Late round in Aug 2014. Based in Israel; founded 2003; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€12M
€11,959,040
Funding rounds
1
Investors
0
distinct backers
Active since
2014-08
latest 2014-08
Funding by year
EUR raised per yearNeuroDerm — funding by year — interactive chart.
Data table
| NeuroDerm — funding by year | |
|---|---|
| 2014 | €12M |
Signals
Medium confidenceRaise-next likelihood7
base rate 37% for Growth/Late
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2014-08-01 | Growth/Late | €12M | — | View deal → |
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Trax€789MIsrael · Software
Global coverage: FundingData